Peripheral blood CD8 + CD38 + HLA ‐ DR + T cells as an adjunctive diagnostic biomarker in adult hemophagocytic lymphohistiocytosis: Comparison with an adapted strict Fardet‐style HScore

Abstract Adult hemophagocytic lymphohistiocytosis (HLH) is diagnostically challenging due to clinical overlap with sepsis, autoimmune disorders, and malignancy‐associated hyperinflammation, and existing criteria were developed primarily in pediatric cohorts. We evaluated peripheral blood CD8 + T‐cell immunophenotyping as a diagnostic adjunct in adults with suspected HLH, compared against an adapted Fardet‐style HScore. This single‐center observational cohort study enrolled 106 consecutive adults with cytopenias and hyperferritinemia undergoing bone marrow examination. Patients were classified as HLH ( n = 50) or non‐HLH ( n = 56) by revised HLH‐2004 criteria with expert adjudication. Multiparametric flow cytometry quantified single‐positive CD8 + CD38 + and CD8 + HLA‐DR + and dual‐positive CD8 + CD38 + HLA‐DR + subsets. Diagnostic performance was assessed by ROC analysis with Youden‐index‐derived cut‐offs. CD8 + CD38 + HLA‐DR + was the strongest flow‐cytometric marker (AUC 0.824). At the Youden‐optimal threshold (>16.71% of parent CD8 + T cells), sensitivity was 78% and specificity 81%; at an exploratory 22.69% threshold (same parent CD8 + subset), sensitivity was 64.0% and specificity 87.5%. Single‐positive CD8 + CD38 + (AUC 0.564) and CD8 + HLA‐DR + (AUC 0.427) subsets did not discriminate. The adapted HScore achieved an AUC of 0.970; at a threshold of >196, sensitivity was 94.0% and specificity was 87.5%. The adapted HScore provided the strongest clinicobiochemical framework. CD8 + CD38 + HLA‐DR + was the best‐performing flow‐cytometric adjunct, offering high specificity for rule‐in in gray‐zone adult HLH. An integrated strategy combining clinical scoring with immune activation profiling is recommended.

Authors

Institutions

Publication Details

Journal
Cytometry Part B Clinical Cytometry
Published
2026-11-17
DOI
https://doi.org/10.1002/cyto.b.70098
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Peripheral blood CD8 + CD38 + HLA ‐ DR + T cells as an adjunctive diagnostic biomarker in adult hemophagocytic lymphohistiocytosis: Comparison with an adapted strict Fardet‐style HScore

Nitin Gupta, Seema Maydeo, Sabina Langer, Pallavi Prakhar et al.
2 links
Cytometry Part B Clinical Cytometry
Autoimmune and Inflammatory Disorders Research
article

Peripheral blood CD8 + CD38 + HLA ‐ DR + T cells as an adjunctive diagnostic biomarker in adult hemophagocytic lymphohistiocytosis: Comparison with an adapted strict Fardet‐style HScore

Nitin Gupta, Seema Maydeo, Sabina Langer, Pallavi Prakhar, Jyoti Kotwal, Saikat Mondal, Deepti Ambalkar
article en

Abstract

Abstract Adult hemophagocytic lymphohistiocytosis (HLH) is diagnostically challenging due to clinical overlap with sepsis, autoimmune disorders, and malignancy‐associated hyperinflammation, and existing criteria were developed primarily in pediatric cohorts. We evaluated peripheral blood CD8 + T‐cell immunophenotyping as a diagnostic adjunct in adults with suspected HLH, compared against an adapted Fardet‐style HScore. This single‐center observational cohort study enrolled 106 consecutive adults with cytopenias and hyperferritinemia undergoing bone marrow examination. Patients were classified as HLH ( n = 50) or non‐HLH ( n = 56) by revised HLH‐2004 criteria with expert adjudication. Multiparametric flow cytometry quantified single‐positive CD8 + CD38 + and CD8 + HLA‐DR + and dual‐positive CD8 + CD38 + HLA‐DR + subsets. Diagnostic performance was assessed by ROC analysis with Youden‐index‐derived cut‐offs. CD8 + CD38 + HLA‐DR + was the strongest flow‐cytometric marker (AUC 0.824). At the Youden‐optimal threshold (>16.71% of parent CD8 + T cells), sensitivity was 78% and specificity 81%; at an exploratory 22.69% threshold (same parent CD8 + subset), sensitivity was 64.0% and specificity 87.5%. Single‐positive CD8 + CD38 + (AUC 0.564) and CD8 + HLA‐DR + (AUC 0.427) subsets did not discriminate. The adapted HScore achieved an AUC of 0.970; at a threshold of >196, sensitivity was 94.0% and specificity was 87.5%. The adapted HScore provided the strongest clinicobiochemical framework. CD8 + CD38 + HLA‐DR + was the best‐performing flow‐cytometric adjunct, offering high specificity for rule‐in in gray‐zone adult HLH. An integrated strategy combining clinical scoring with immune activation profiling is recommended.

Cytometry Part B Clinical Cytometry
Sir Ganga Ram Hospital (IN)
Good health and well-being
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon